There seems to be some good news for children. The European Medicines Agency has cleared the Moderna Vaccine for kids from 12-17 years of age. That can be termed as children in their pre-teens and teens as well.
European Agency Clears Moderna Vaccine For Children Aged 12-17 Years
This is the first time a shot has been authorized for people under 18 years of age. The European Union Drug regulator has said that research on almost 3,700 children has shown a positive antibody response. Until recently, there was only one option in the market for 12+ children.
It was the one made by Pfizer and BioNTech. In North America and Europe, these were in circulation very recently.
Further Findings On The Vaccine
The U.S. Food and Drug Administration is currently thinking, whether or not to extend the vaccine Moderna to the above age group. The global immunization results are not as good. Most of the population or a certain segment has shown reluctance to vaccines. Moreover, there is a shortage of vaccines for adults as well.
The WHO and developed nations are making arrangements to donated doses to other, less privileged nations. Fewer than 2 percent in certain nations have received the vaccine. Millions of doses have been administered to adults across the globe.
The two-dose vaccine is potent enough. In the above-mentioned study of 3,700 children aged between 12-17 years, the vaccine has produced the same immune response, as it would in adults.
Some recipients have shown fatigue, arm pain, headache, and fever symptoms. However, that is common in these kinds of antibody-inducing vaccines. The same results have cropped up, in terms of adult vaccination.
However, there is a word for caution here. The U.S. and European regulators have found out that, some unknown repercussions are been seen in children. They are chest pain and heart inflammation.
In the U.S. about 14 percent of children have been infected with the virus. However, the young ones are not as likely to get ill, unlike the older generation. According to a recent tally, about 350 young ones have succumbed to the virus.
Status Of Vaccinated Population In The U.S.
As of date, only below half the U.S. population has been vaccinated. And, just one-fourth of youngsters aged 12-15 years have received the Pfizer vaccine released in May 2021. According to the reports generated by the CDC, only 37 percent of 16-17-year-olds have been vaccinated.
Bothe vaccine makers have started testing on kids younger than 12 years. These studies are more complicated. Teens have received the same doses as adults. However, in the case of kids younger than 11 years, smaller doses can suffice. The first results of the tests on children from elementary schools are coming up in September.
The European Union drug regulator said, that it continues to monitor the safety and effects of the vaccines in children. Most countries have authorized the use of the Pfizer vaccine on kids aged 12-17, but not all.
Most countries are further ramping up their adult vaccination drives. In Britain, the regulators have cleared the drives by Pfizer, for 12-15-year-olds. However, health officials have not started any drive as of now.
In spite of some after-effects of the vaccines as reported, the Center for Disease Control has said that the vaccines are quite safe for children. The vaccines have supposedly been made under strict laboratory conditions and have been used on a larger part of the population.
The children need to take their second shot after 3 weeks of their first dose. Children may see some side effects, as is the case with all kinds of vaccines. The effects include pain, redness, and swelling in mild cases. And, these effects can make your children less active in the short term. However, they are essential.